Navamedic ASA : Approved Information Memorandum

Reference is made to the stock exchange notice dated 4 August 2015 regarding Navamedic ASA's acquisition of 100% of the shares in Observe Medical International AB (OM) (the "Transaction").  

The attached Information Memorandum has been prepared by Navamedic ASA in order to provide information about the Company and its business in connection with the purchase of OM.

Oslo Stock Exchange has approved the Information Memorandum dated 14 September 2014.

The Information Memorandum does not constitute an offer to sell, or a solicitation of an offer to buy, any of the shares or other securities issued by Navamedic ASA.

The Information Memorandum is enclosed hereto and will also be available at the Company's website:

For further information, please contact Bjørn Lindholt, CFO Navamedic ASA,, tel. +47 930 06 601.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.